492 related articles for article (PubMed ID: 36480479)
1. Reduced Risk for Mpox After Receipt of 1 or 2 Doses of JYNNEOS Vaccine Compared with Risk Among Unvaccinated Persons - 43 U.S. Jurisdictions, July 31-October 1, 2022.
Payne AB; Ray LC; Cole MM; Canning M; Houck K; Shah HJ; Farrar JL; Lewis NM; Fothergill A; White EB; Feldstein LR; Roper LE; Lee F; Kriss JL; Sims E; Spicknall IH; Nakazawa Y; Gundlapalli AV; Shimabukuro T; Cohen AL; Honein MA; Mermin J; Payne DC
MMWR Morb Mortal Wkly Rep; 2022 Dec; 71(49):1560-1564. PubMed ID: 36480479
[TBL] [Abstract][Full Text] [Related]
2. Incidence of Monkeypox Among Unvaccinated Persons Compared with Persons Receiving ≥1 JYNNEOS Vaccine Dose - 32 U.S. Jurisdictions, July 31-September 3, 2022.
Payne AB; Ray LC; Kugeler KJ; Fothergill A; White EB; Canning M; Farrar JL; Feldstein LR; Gundlapalli AV; Houck K; Kriss JL; Lewis NM; Sims E; Smith DK; Spicknall IH; Nakazawa Y; Damon IK; Cohn AC; Payne DC
MMWR Morb Mortal Wkly Rep; 2022 Oct; 71(40):1278-1282. PubMed ID: 36201401
[TBL] [Abstract][Full Text] [Related]
3. Demographic and Clinical Characteristics of Mpox in Persons Who Had Previously Received 1 Dose of JYNNEOS Vaccine and in Unvaccinated Persons - 29 U.S. Jurisdictions, May 22-September 3, 2022.
Farrar JL; Lewis NM; Houck K; Canning M; Fothergill A; Payne AB; Cohen AL; Vance J; Brassil B; Youngkin E; Glenn B; Mangla A; Kupferman N; Saunders K; Meza C; Nims D; Soliva S; Blouse B; Henderson T; Banerjee E; White B; Birn R; Stadelman AM; Abrego M; McLafferty M; Eberhart MG; Pietrowski M; De León SM; Creegan E; Diedhiou A; Wiedeman C; Murray-Thompson J; McCarty E; Marcinkevage J; Kocharian A; Torrone EA; Ray LC; Payne DC;
MMWR Morb Mortal Wkly Rep; 2022 Dec; 71(5152):1610-1615. PubMed ID: 36580416
[TBL] [Abstract][Full Text] [Related]
4. Estimated Effectiveness of JYNNEOS Vaccine in Preventing Mpox: A Multijurisdictional Case-Control Study - United States, August 19, 2022-March 31, 2023.
Dalton AF; Diallo AO; Chard AN; Moulia DL; Deputy NP; Fothergill A; Kracalik I; Wegner CW; Markus TM; Pathela P; Still WL; Hawkins S; Mangla AT; Ravi N; Licherdell E; Britton A; Lynfield R; Sutton M; Hansen AP; Betancourt GS; Rowlands JV; Chai SJ; Fisher R; Danza P; Farley M; Zipprich J; Prahl G; Wendel KA; Niccolai L; Castilho JL; Payne DC; Cohn AC; Feldstein LR; ;
MMWR Morb Mortal Wkly Rep; 2023 May; 72(20):553-558. PubMed ID: 37200229
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness of JYNNEOS Vaccine Against Diagnosed Mpox Infection - New York, 2022.
Rosenberg ES; Dorabawila V; Hart-Malloy R; Anderson BJ; Miranda W; O'Donnell T; Gonzalez CJ; Abrego M; DelBarba C; Tice CJ; McGarry C; Mitchell EC; Boulais M; Backenson B; Kharfen M; McDonald J; Bauer UE
MMWR Morb Mortal Wkly Rep; 2023 May; 72(20):559-563. PubMed ID: 37339074
[TBL] [Abstract][Full Text] [Related]
6. Receipt of First and Second Doses of JYNNEOS Vaccine for Prevention of Monkeypox - United States, May 22-October 10, 2022.
Kriss JL; Boersma PM; Martin E; Reed K; Adjemian J; Smith N; Carter RJ; Tan KR; Srinivasan A; McGarvey S; McGehee J; Henderson D; Aleshire N; Gundlapalli AV
MMWR Morb Mortal Wkly Rep; 2022 Oct; 71(43):1374-1378. PubMed ID: 36301741
[TBL] [Abstract][Full Text] [Related]
7. JYNNEOS Vaccination Coverage Among Persons at Risk for Mpox - United States, May 22, 2022-January 31, 2023.
Owens LE; Currie DW; Kramarow EA; Siddique S; Swanson M; Carter RJ; Kriss JL; Boersma PM; Lee FC; Spicknall I; Hurley E; Zlotorzynska M; Gundlapalli AV
MMWR Morb Mortal Wkly Rep; 2023 Mar; 72(13):342-347. PubMed ID: 36995962
[TBL] [Abstract][Full Text] [Related]
8. Safety Monitoring of JYNNEOS Vaccine During the 2022 Mpox Outbreak - United States, May 22-October 21, 2022.
Duffy J; Marquez P; Moro P; Weintraub E; Yu Y; Boersma P; Donahue JG; Glanz JM; Goddard K; Hambidge SJ; Lewin B; Lewis N; Rouse D; Shimabukuro T
MMWR Morb Mortal Wkly Rep; 2022 Dec; 71(49):1555-1559. PubMed ID: 36480476
[TBL] [Abstract][Full Text] [Related]
9. Progress Toward Equitable Mpox Vaccination Coverage: A Shortfall Analysis - United States, May 2022-April 2023.
Kota KK; Chesson H; Hong J; Zelaya C; Spicknall IH; Riser AP; Hurley E; Currie DW; Lash RR; Carnes N; Concepción-Acevedo J; Ellington S; Belay ED; Mermin J
MMWR Morb Mortal Wkly Rep; 2023 Jun; 72(23):627-632. PubMed ID: 37289660
[TBL] [Abstract][Full Text] [Related]
10. Vaccine Effectiveness of JYNNEOS against Mpox Disease in the United States.
Deputy NP; Deckert J; Chard AN; Sandberg N; Moulia DL; Barkley E; Dalton AF; Sweet C; Cohn AC; Little DR; Cohen AL; Sandmann D; Payne DC; Gerhart JL; Feldstein LR
N Engl J Med; 2023 Jun; 388(26):2434-2443. PubMed ID: 37199451
[TBL] [Abstract][Full Text] [Related]
11. Reduced Odds of Mpox-Associated Hospitalization Among Persons Who Received JYNNEOS Vaccine - California, May 2022-May 2023.
Schildhauer S; Saadeh K; Vance J; Quint J; Salih T; Lo T; Keinde A; Chojolan E; Gotlieb E; Ramos M; Chapman E; Peters P; Watson J; Johnson KA; Tang EC; Jacobson K; Snyder RE
MMWR Morb Mortal Wkly Rep; 2023 Sep; 72(36):992-996. PubMed ID: 37676838
[TBL] [Abstract][Full Text] [Related]
12. Monkeypox Virus Infections After 2 Preexposure Doses of JYNNEOS Vaccine - United States, May 2022-May 2024.
Guagliardo SAJ; Kracalik I; Carter RJ; Braden C; Free R; Hamal M; Tuttle A; McCollum AM; Rao AK
MMWR Morb Mortal Wkly Rep; 2024 May; 73(20):460-466. PubMed ID: 38781111
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness of one dose of MVA-BN smallpox vaccine against mpox in England using the case-coverage method: an observational study.
Bertran M; Andrews N; Davison C; Dugbazah B; Boateng J; Lunt R; Hardstaff J; Green M; Blomquist P; Turner C; Mohammed H; Cordery R; Mandal S; Campbell C; Ladhani SN; Ramsay M; Amirthalingam G; Bernal JL
Lancet Infect Dis; 2023 Jul; 23(7):828-835. PubMed ID: 36924787
[TBL] [Abstract][Full Text] [Related]
14. Racial and Ethnic Disparities in Mpox Cases and Vaccination Among Adult Males - United States, May-December 2022.
Kota KK; Hong J; Zelaya C; Riser AP; Rodriguez A; Weller DL; Spicknall IH; Kriss JL; Lee F; Boersma P; Hurley E; Hicks P; Wilkins C; Chesson H; Concepción-Acevedo J; Ellington S; Belay E; Mermin J
MMWR Morb Mortal Wkly Rep; 2023 Apr; 72(15):398-403. PubMed ID: 37053122
[TBL] [Abstract][Full Text] [Related]
15. Demographic and Clinical Characteristics of Mpox in Persons Who Had Previously Received 1 Dose of JYNNEOS Vaccine and in Unvaccinated Persons - 29 U.S. Jurisdictions, May 22-September 3, 2022.
Farrar JL; Lewis NM; Houck K; Canning M; Fothergill A; Payne AB; Cohen AL; Vance J; Brassil B; Youngkin E; Glenn B; Mangla A; Kupferman N; Saunders K; Meza C; Nims D; Soliva S; Blouse B; Henderson T; Banerjee E; White B; Birn R; Stadelman AM; Abrego M; McLafferty M; Eberhart MG; Pietrowski M; De León SM; Creegan E; Diedhiou A; Wiedeman C; Murray-Thompson J; McCarty E; Marcinkevage J; Kocharian A; Torrone EA; Ray LC; Payne DC;
Am J Transplant; 2023 Feb; 23(2):298-303. PubMed ID: 36695684
[No Abstract] [Full Text] [Related]
16. Uptake of Mpox vaccination among transgender people and gay, bisexual and other men who have sex with men among sexually-transmitted infection clinic clients in Vancouver, British Columbia.
Gilbert M; Ablona A; Chang HJ; Grennan T; Irvine MA; Sarai Racey C; Salway T; Naus M; Dawar M; Ogilvie G
Vaccine; 2023 Apr; 41(15):2485-2494. PubMed ID: 36894397
[TBL] [Abstract][Full Text] [Related]
17. Demographic Disparities in Mpox Vaccination Series Completion, by Route of Vaccine Administration - California, August 9, 2022-March 31, 2023.
Salih T; Vance J; Quint J; Meza B; McNitt L; Lincoln WU; Schechter R
MMWR Morb Mortal Wkly Rep; 2023 Jul; 72(30):827-832. PubMed ID: 37498796
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness of JYNNEOS vaccine against symptomatic mpox disease in adult men in Los Angeles County, August 29, 2022 to January 1, 2023.
Yeganeh N; Yin S; Moir O; Danza P; Kim M; Finn L; Fisher R; Kulkarni S; Perez M; Poortinga K; Garland W; Foo C; Haddix M; Archer R; Frey N; Balter S; Singhal R; Kim A
Vaccine; 2024 May; ():. PubMed ID: 38789368
[TBL] [Abstract][Full Text] [Related]
19. Adverse Reactions After Intradermal Vaccination With JYNNEOS for Mpox in Korea.
Lim SY; Jung YM; Kim Y; Kim G; Jeon J; Chin B; Kim MK
J Korean Med Sci; 2024 Mar; 39(8):e100. PubMed ID: 38442725
[TBL] [Abstract][Full Text] [Related]
20. Mpox Knowledge, Attitudes, and Practices Among Persons Presenting for JYNNEOS Vaccination-District of Columbia, August to October 2022.
Hassan R; Wondmeneh S; Gonzalez Jimenez N; Chapman K; Mangla A; Ashley P; Willut C; Lee M; Rhodes T; Gillani S; Copen C; Jackson DA; Waltenburg M; Delaney KP; Miles G; Agnew-Brune C; Oakley LP;
Sex Transm Dis; 2024 Jan; 51(1):47-53. PubMed ID: 37921836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
